Pharsight

Drugs that contain Propranolol Hydrochloride

1. Hemangeol patents expiration

HEMANGEOL's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8338489 PIERRE FABRE DERMA Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
Oct, 2028

(4 years from now)

US8987262 PIERRE FABRE DERMA Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
Oct, 2028

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE) Mar 14, 2021
New Product(NP) Mar 14, 2017
Orphan Drug Exclusivity(ODE-62) Mar 14, 2021

Market Authorisation Date: 14 March, 2014

Treatment: Method to treat hemangioma.; Method to treat infantile hemangioma

Dosage: SOLUTION;ORAL

How can I launch a generic of HEMANGEOL before it's drug patent expiration?
More Information on Dosage

HEMANGEOL family patents

Family Patents

2. Innopran Xl patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6500454 ANI PHARMS Timed, sustained release systems for propranolol
Oct, 2021

(2 years ago)

Market Authorisation Date: 12 March, 2003

Treatment: NA

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

INNOPRAN XL family patents

Family Patents